Retaglutide is a cutting-edge GLP-1 receptor agonist currently under research for the treatment of obesity. This therapy works by stimulating the effects of glucagon-like peptide-1 (GLP-1), a naturally occurring https://jaysonzsys587678.frewwebs.com/39067091/retaglutide-a-promising-glp-1-receptor-agonist